Synthesis of Thieno[2,3-d]oxazines and Thieno[2,3-d]thiazines as Subtype Specific Kainate Receptor Antagonists

Author(s): D. Briel, A. Rybak, S. Mann, C. Kronbach, K. Unverferth.

Journal Name: Current Medicinal Chemistry

Volume 16 , Issue 35 , 2009

Become EABM
Become Reviewer

Abstract:

For the development of new antiepileptics the kainate receptors, GluR6 and GluR5, are important targets. Based on the anticonvulsant effects of chinazolines and thieno[2,3-d]pyrimidines that are known from the literature, thieno[2,3-d][1.3]oxazines were synthesized and studied for their inhibitory properties at GluR6 and GluR5 receptors. The strongest inhibitor activity was observed with 5-methyl-6-phenyl-thieno[2,3-d][1.3]oxazines with C1 or C3-substituents in position 2 (3b-f). The 2-trihalide-methyl-substituted compounds 3c and 3d were the most active inhibitors at the GluR5- receptor (IC50=23.4 μmol, 16 μl). The 2-isopropyl-substituted compound 3f displayed the strongest activity at the GluR6- receptor (IC50=8.7 μmol). A number of thieno[2,3-d][1.3]thiazines and thieno[2,3-d]pyrimidines that were synthesized from the thieno[2,3][1.3]oxazines did not show any activity.

Keywords: Glutamate receptor antagonists, kainate receptor antagonists, anticonvulsives, thieno[2,3-d][1.3]oxazines, thieno[2,3-d][1.3]thiazines, thieno[2,3-d]-pyrimidines

Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 16
ISSUE: 35
Year: 2009
Page: [4704 - 4711]
Pages: 8
DOI: 10.2174/092986709789878283
Price: $58

Article Metrics

PDF: 9